◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
安科生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 2.5B 2.9B 2.3B 2.2B 1.7B
Revenue Growth % -11.5% 23.0% 7.5% 27.5% --
Total Revenue 2.5B 2.9B 2.3B 2.2B 1.7B
Cost Of Revenue 573.0M 620.0M 503.0M 432.0M 361.0M
+Gross Profit 2.0B 2.2B 1.8B 1.7B 1.3B
Gross Margin % 77.4% 78.4% 78.4% 80.1% 78.8%
Total Operating Cost 1.8B 2.0B 1.6B 1.9B 1.3B
Selling Expenses 819.0M 831.0M 734.0M 812.0M 680.0M
Admin Expenses 167.0M 203.0M 140.0M 133.0M 115.0M
Rd Expenses 201.0M 255.0M 166.0M 167.0M 129.0M
Finance Expenses -1.6M -3.8M -2.4M -7.1M -11.8M
+Operating Income 806.0M 924.0M 842.0M 297.0M 424.0M
Operating Margin % 31.8% 32.2% 36.1% 13.7% 24.9%
Non Operating Income 1.0M 65,200 247,400 296,300 1.3M
Non Operating Expenses 4.4M 4.1M 8.4M 2.6M 9.2M
Investment Income 15.4M -4.7M 4.8M 6.1M -2.2M
Fair Value Change Income 10.5M -411,100 36.3M 19.3M 1.5M
Asset Disposal Income 1.1M 120,700 -1.2M 1.7M -22,400
Asset Impairment Loss 7.9M 17.5M 27.6M 346.0M 15.2M
Other Income 41.1M 31.4M 36.8M 20.6M 47.1M
Income Before Tax 803.0M 920.0M 834.0M 295.0M 416.0M
Income Tax 87.2M 61.3M 96.2M 91.7M 69.6M
+Net Income 716.0M 859.0M 738.0M 203.0M 347.0M
Net Margin % 28.2% 30.0% 31.7% 9.4% 20.4%
Net Income Attributable 707.0M 847.0M 703.0M 207.0M 359.0M
Minority Interest 8.9M 11.4M 34.4M -3.2M -12.4M
Eps Basic 0.42 0.51 0.43 0.13 0.22
Eps Diluted 0.42 0.51 0.43 0.13 0.22
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 299.0M 260.0M 325.0M 323.0M 248.0M
Trading Financial Assets 1.1B 1.2B 843.0M 805.0M 646.0M
Accounts Receivable 442.0M 550.0M 405.0M 434.0M 406.0M
Notes Receivable -- -- -- -- --
Notes And Accounts Receivable 442.0M 550.0M 405.0M 434.0M 406.0M
Prepayments 8.2M 25.7M 42.1M 16.5M 11.3M
Inventory 297.0M 235.0M 210.0M 181.0M 155.0M
Total Current Assets 2.3B 2.3B 1.9B 1.9B 1.6B
Long Term Equity Investment 122.0M 167.0M 196.0M 125.0M 133.0M
Fixed Assets -- 706.0M 700.0M 626.0M 630.0M
Fixed Assets Total 738.0M 706.0M 700.0M 626.0M 630.0M
Construction In Progress -- 673.0M 446.0M 229.0M 137.0M
Construction In Progress Total 800.0M 673.0M 446.0M 229.0M 137.0M
Intangible Assets 412.0M 450.0M 276.0M 126.0M 119.0M
Long Term Deferred Expenses 19.1M 7.8M 7.4M 9.1M 10.8M
Total Non Current Assets 2.9B 2.6B 2.3B 1.7B 1.9B
Total Assets 5.1B 5.0B 4.3B 3.7B 3.5B
Short Term Borrowings 5.0M -- 3.0M -- --
Accounts Payable 195.0M 197.0M 151.0M 141.0M 109.0M
Advance Receipts -- -- -- -- --
Contract Liabilities 19.3M 24.4M 28.0M 19.5M 13.4M
Total Current Liabilities 668.0M 847.0M 676.0M 627.0M 473.0M
Long Term Borrowings -- -- -- -- --
Total Non Current Liabilities 168.0M 171.0M 179.0M 139.0M 104.0M
Total Liabilities 835.0M 1.0B 855.0M 766.0M 576.0M
Paid In Capital 1.7B 1.7B 1.7B 1.6B 1.4B
Capital Reserve 509.0M 520.0M 406.0M 187.0M 443.0M
Surplus Reserve 438.0M 369.0M 293.0M 218.0M 180.0M
Retained Earnings 1.6B 1.4B 1.0B 743.0M 847.0M
Minority Equity 176.0M 195.0M 193.0M 117.0M 92.8M
Equity Attributable 4.1B 3.7B 3.2B 2.8B 2.8B
Total Equity 4.3B 3.9B 3.4B 2.9B 2.9B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 2.5B 2.5B 2.3B 1.9B 1.6B
Tax Refunds Received -- -- 2.0M 3.3M --
Total Operating Cash Inflow 2.5B 2.6B 2.3B 2.0B 1.7B
Cash Paid For Goods 244.0M 162.0M 203.0M 107.0M 149.0M
Cash Paid To Employees 606.0M 582.0M 461.0M 367.0M 303.0M
Taxes Paid 224.0M 227.0M 235.0M 197.0M 167.0M
Total Operating Cash Outflow 1.8B 1.6B 1.6B 1.4B 1.3B
Operating Cash Flow 685.0M 953.0M 699.0M 592.0M 465.0M
Total Investing Cash Inflow 1.3B 873.0M 833.0M 777.0M 523.0M
Total Investing Cash Outflow 1.4B 1.5B 1.4B 948.0M 886.0M
Investing Cash Flow -170.0M -617.0M -544.0M -171.0M -363.0M
Cash From Borrowings 5.0M -- 3.0M -- --
Dividends And Interest Paid 418.0M 414.0M 328.0M 274.0M 159.0M
Debt Repayments -- 3.0M -- 14.0M 14.0M
Total Financing Cash Inflow 5.0M 41.1M 224.0M 15.0M 47.1M
Total Financing Cash Outflow 480.0M 442.0M 378.0M 291.0M 173.0M
Financing Cash Flow -475.0M -401.0M -153.0M -276.0M -126.0M
Net Change In Cash 39.8M -65.4M 2.0M 145.0M -25.0M
Ending Cash Balance 299.0M 259.0M 324.0M 322.0M 177.0M
Capex 117.0M 195.0M 474.0M 131.0M 139.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...